Clinical outcomes of coronary artery bifurcation disease patients underwent Culotte two-stent technique: a single center experience.
Chang CF, Chang KH, Lai CH, Lin TH, Liu TJ, Lee WL, Su CS.
BMC Cardiovasc Disord. 2019 Sep 2;19(1):208. doi: 10.1186/s12872-019-1192-2.
Comparing two-stent strategies for bifurcation coronary lesions: which vessel should be stented first, the main vessel or the side branch?
Shin DH, Park KW, Koo BK, Oh IY, Seo JB, Gwon HC, Jeong MH, Seong IW, Rha SW, Yang JY, Park SJ, Yoon JH, Han KR, Park JS, Hur SH, Tahk SJ, Kim HS.
J Korean Med Sci. 2011 Aug;26(8):1031-40. doi: 10.3346/jkms.2011.26.8.1031. Epub 2011 Jul 27.
Long-term clinical outcomes of percutaneous coronary intervention for ostial left main coronary artery disease.
Sui Y, Qian J, Guan C, Xu Y, Wu N, Yang W, Wu Y, Dou K, Yang Y, Qiao S, Xu B.
EuroIntervention. 2023 Apr 24;18(17):1446-1455. doi: 10.4244/EIJ-D-22-00909.
Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large-size vessels.
Sharma SK.
Catheter Cardiovasc Interv. 2005 May;65(1):10-6. doi: 10.1002/ccd.20363.
Stenting strategy for coronary artery bifurcation with drug-eluting stents: a meta-analysis of nine randomised trials and systematic review.
Gao XF, Zhang YJ, Tian NL, Wu W, Li MH, Bourantas CV, Jiang XM, Wang ZM, Li B, Mao WX, Zhang JJ, Chen SL.
EuroIntervention. 2014 Sep;10(5):561-9. doi: 10.4244/EIJY14M06_06.
[Use of drug-coated balloons for interventions on bifurcation lesions of coronary arteries].
Kuropiĭ TS, Utegenov RB, Khelimskiĭ DA, Badoian AG, Éraliev TK, Krest'ianinov OV.
Angiol Sosud Khir. 2021;27(3):46-52. doi: 10.33529/ANGIO2021319.
Two-Year Outcomes and Predictors of Target Lesion Revascularization for Non-Left Main Coronary Bifurcation Lesions Following Two-Stent Strategy With 2nd-Generation Drug-Eluting Stents.
Ohya M, Morimoto T, Kubo S, Habara S, Kuwayama A, Miura K, Shimada T, Amano H, Otsuru S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.
Circ J. 2018 Feb 23;82(3):798-806. doi: 10.1253/circj.CJ-17-1092. Epub 2017 Dec 19.
Impact of procedural and patient-related risks on 1-year outcomes for patients treated with 1-month dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy after biodegradable-polymer drug-eluting stent implantation.
Shimada R, Ishida M, Takahashi F, Niiyama M, Ishisone T, Matsumoto Y, Taguchi Y, Osaki T, Nishiyama O, Endo H, Sakamoto R, Tanaka K, Koeda Y, Kimura T, Goto I, Ninomiya R, Sasaki W, Shimada K, Itoh T, Morino Y; REIWA investigators.
Cardiovasc Interv Ther. 2025 Apr;40(2):327-336. doi: 10.1007/s12928-025-01087-9. Epub 2025 Jan 17.
Drug-coated balloon combined with drug-eluting stent for the treatment of coronary bifurcation lesions: insights from the HYPER study.
Pellegrini D, Donahue M, Regazzoli D, Tedeschi D, Loffi M, Pellicano M, De Blasio G, Tespili M, Guagliumi G, Ielasi A.
Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C79-C83. doi: 10.1093/eurheartjsupp/suad011. eCollection 2023 May.
Three-year outcome of drug-eluting stent implantation for coronary artery bifurcation lesions.
Stinis CT, Hu SP, Price MJ, Teirstein PS.
Catheter Cardiovasc Interv. 2010 Feb 15;75(3):309-14. doi: 10.1002/ccd.22302.
